FR2589733A1 - Compositions pharmaceutiques contenant la 2-methyl-thiazolo-(4, 5-c) quinoleine et leur procede de preparation - Google Patents

Compositions pharmaceutiques contenant la 2-methyl-thiazolo-(4, 5-c) quinoleine et leur procede de preparation Download PDF

Info

Publication number
FR2589733A1
FR2589733A1 FR8615654A FR8615654A FR2589733A1 FR 2589733 A1 FR2589733 A1 FR 2589733A1 FR 8615654 A FR8615654 A FR 8615654A FR 8615654 A FR8615654 A FR 8615654A FR 2589733 A1 FR2589733 A1 FR 2589733A1
Authority
FR
France
Prior art keywords
quinoline
methyl
addition salt
acid addition
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR8615654A
Other languages
English (en)
French (fr)
Inventor
Jozsef Knoll
Berenyi-Nee-Edit Poldermann
Budai-Nee-Katalin Simonyi
Berta Knoll
Zsuzsa Furts
Julia Timar
Gabriella Zsila
Ildiko Niklya
Lujza Petocz
Attila Mandi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Gyógyszergyár Zrt
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Gyógyszergyár Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Gyógyszergyár Zrt filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of FR2589733A1 publication Critical patent/FR2589733A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8615654A 1985-11-12 1986-11-12 Compositions pharmaceutiques contenant la 2-methyl-thiazolo-(4, 5-c) quinoleine et leur procede de preparation Pending FR2589733A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU854302A HU196308B (en) 1985-11-12 1985-11-12 Process for producing pharmaceutical compositions containing 2-methyl-thiazolo/4,5-c/quinoline as active component

Publications (1)

Publication Number Publication Date
FR2589733A1 true FR2589733A1 (fr) 1987-05-15

Family

ID=10967583

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8615654A Pending FR2589733A1 (fr) 1985-11-12 1986-11-12 Compositions pharmaceutiques contenant la 2-methyl-thiazolo-(4, 5-c) quinoleine et leur procede de preparation

Country Status (15)

Country Link
US (1) US4778811A (enExample)
JP (1) JPS62161791A (enExample)
AU (1) AU587505B2 (enExample)
BE (1) BE905718A (enExample)
CH (1) CH669729A5 (enExample)
DE (1) DE3638573A1 (enExample)
FR (1) FR2589733A1 (enExample)
GB (1) GB2182561B (enExample)
HU (1) HU196308B (enExample)
IL (1) IL80609A0 (enExample)
IT (1) IT1214558B (enExample)
NL (1) NL8602877A (enExample)
SE (1) SE8604838L (enExample)
YU (1) YU192086A (enExample)
ZA (1) ZA868582B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0288072A3 (de) * 1987-04-24 1988-12-28 Egis Gyogyszergyar 3-(Amino)-4-äthylthio)-chinolin oder dessen Säureadditionssalze zur Verwendung als Arzneimittel und diese[s] enthaltende Arzneimittel
EP0327052A3 (en) * 1988-02-01 1990-12-12 Rorer International (Overseas) Inc. Use of quinoline derivatives for making a medicament effective in the prevention and treatment of ulcers

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197019B (en) * 1985-11-12 1989-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing thiqzolo (4,5-c) quinoline derivatives and pharmaceuticals comprising same
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666916A (en) * 1985-11-08 1987-05-19 Ciba-Geigy Corporation Hexahydro-(1)-benzo-(pyrano and thiopyrano) (4,3-C)pyridines, useful as serotin-2 blocking agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 69, février 1947, pages 365-371, Washington, US; G.BRYANT BACHMAN et al.: "Quinoline derivatives from 3-nitro-4-hydroxyquinoline" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0288072A3 (de) * 1987-04-24 1988-12-28 Egis Gyogyszergyar 3-(Amino)-4-äthylthio)-chinolin oder dessen Säureadditionssalze zur Verwendung als Arzneimittel und diese[s] enthaltende Arzneimittel
EP0327052A3 (en) * 1988-02-01 1990-12-12 Rorer International (Overseas) Inc. Use of quinoline derivatives for making a medicament effective in the prevention and treatment of ulcers

Also Published As

Publication number Publication date
GB8627042D0 (en) 1986-12-10
DE3638573A1 (de) 1987-05-14
NL8602877A (nl) 1987-06-01
IT1214558B (it) 1990-01-18
IT8622313A0 (it) 1986-11-12
CH669729A5 (enExample) 1989-04-14
ZA868582B (en) 1987-07-29
BE905718A (fr) 1987-05-07
AU587505B2 (en) 1989-08-17
HUT44562A (en) 1988-03-28
SE8604838L (sv) 1987-05-13
SE8604838D0 (sv) 1986-11-12
HU196308B (en) 1988-11-28
AU6508686A (en) 1987-05-14
GB2182561B (en) 1989-12-06
YU192086A (en) 1987-12-31
US4778811A (en) 1988-10-18
IL80609A0 (en) 1987-02-27
JPS62161791A (ja) 1987-07-17
GB2182561A (en) 1987-05-20

Similar Documents

Publication Publication Date Title
EP0165919A1 (fr) (R)-alpha-éthyl-2-oxo-1-pyrrolidineacétamide
MC1220A1 (fr) Nouveaux derives d'imidazolidine
CH647757A5 (fr) Derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee.
CH635813A5 (fr) 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant.
LU79824A1 (fr) Nouveaux hexahydro-1-hydroxy-9-hydroxymethyl-6h-dibenzo-(b,d)pyranes substitues en position 3,leur procede de preparation et composition pharmaceutique les contenant
EP0012639B1 (fr) Nouveaux dérivés de l'acide 3-quinoléine carboxylique, leur procédé de préparation, leur application comme médicament et les compositions pharmaceutiques les renfermant
FR2591596A1 (fr) Nouvelles 4h-triazolo(4,3-a)(1,4)benzodiazepines, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
CH638187A5 (fr) 3-(2-hydroxy-4(substituant)-phenyl)-azacycloalcanes et medicament les contenant.
FR2481118A1 (fr) Application a titre de medicaments de derives substitues de l'acide phenyl-4-oxo-2-butenoique
EP0138721A2 (fr) Nouveaux benzenesulfonyl-lactames, leur procédé de préparation et leur application comme substance active de compositions pharmaceutiques
CA2000091A1 (fr) Derives de la benzoxazolinone, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2730490A1 (fr) Derives 1-(2-(vinyl-substitues))-3,4-dihydro-5h-2,3- benzodiazepine
FR2536398A1 (fr) Nouveaux composes heterocycliques
CA2143251A1 (fr) Utilisation d'un derive tricyclique pour l'obtention de medicaments destines au traitement des troubles mnemo-cognitifs
FR2610932A1 (fr) Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament
FR2480285A1 (fr) 2-(3-(4-(3-chloro-4-fluorophenyl) -1- piperazinyl) propyl)-1,2,4-triazolo(4,3-a)pyridin-3 (2h)-one, procede de preparation et compositions pharmaceutiques
FR2570701A1 (fr) Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
FR2499981A1 (fr) Acides amino-2 halogenobenzoyl-3 methylphenylacetiques et leurs esters et sels utiles comme medicaments anti-inflammatoires et analgesiques
FR2559771A1 (fr) Derives de la 3-pyrrolidinopropiophenone et procede pour leur preparation
MC2105A1 (fr) Derives de tetrahydronaphtalene
BE700422A (enExample)
US4778811A (en) Pharmaceutical compositions of 2-methyl-thiazolo[4,5-c]quinoline
CH658786A5 (fr) Medicaments qui contiennent d'alpha-(n-pyrrolyl)-acides ou de leurs sels ou esters.
FR2518537A1 (fr) Nouveaux derives de l'acide phenylacetique, leur preparation et compositions les contenant
EP1007522B1 (fr) 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, sa preparation et son utilisation therapeutique